Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Gill

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pediatric Radiology|August 9, 2025
Superior vena cava (SVC) stent placement in children and young adults with congenitally normal cardiac and caval anatomyMichael Leshen, Hawkins C Matthew, Jay Shah, et al.
Medical Education Online|February 14, 2024
Addressing unprofessional behaviors in the clinical learning environment: lessons from a multi-year virtual, intergenerational, interdisciplinary workshopStacey Rose, Anita Kusnoor, Phuong Huynh, et al.
JAMIA Open|March 11, 2022
User-centered design of central venous access device documentationSwaminathan Kandaswamy, Anne Gill, Shellie Wood, et al.
Medical Devices (Auckland, N.Z.)|October 28, 2016
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experienceKristina Callis Duffin, Michael Bukhalo, Margaret A Bobonich, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 24, 2015
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)Mark C Genovese, Gregg J Silverman, Paul Emery, et al.
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
American Journal of Medical Genetics. Part A|June 11, 2026
Disparities in Diagnostic Yield of Genetic Testing in Children and Adolescents With Vascular Malformations and/or Overgrowth: A Single Site ExperienceJanette diMonda, Rana Al-Jaberi, Mustafa A Khader, et al.
The Journal of Pediatrics|January 13, 2005
Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effectJan M Wit, Lyset T M Rekers-Mombarg, Gordon B Cutler, et al.
Annals of the Rheumatic Diseases|April 16, 2015
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind studyJosef S Smolen, Michael E Weinblatt, Désirée van der Heijde, et al.
Pediatrics|February 20, 2021
Improving Parent-Child Interactions in Pediatric Health Care: A Two-Site Randomized Controlled TrialErin Roby, Elizabeth B Miller, Daniel S Shaw, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pediatric Radiology|August 9, 2025
Superior vena cava (SVC) stent placement in children and young adults with congenitally normal cardiac and caval anatomyMichael Leshen, Hawkins C Matthew, Jay Shah, et al.
Medical Education Online|February 14, 2024
Addressing unprofessional behaviors in the clinical learning environment: lessons from a multi-year virtual, intergenerational, interdisciplinary workshopStacey Rose, Anita Kusnoor, Phuong Huynh, et al.
JAMIA Open|March 11, 2022
User-centered design of central venous access device documentationSwaminathan Kandaswamy, Anne Gill, Shellie Wood, et al.
Medical Devices (Auckland, N.Z.)|October 28, 2016
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experienceKristina Callis Duffin, Michael Bukhalo, Margaret A Bobonich, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 24, 2015
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)Mark C Genovese, Gregg J Silverman, Paul Emery, et al.
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
American Journal of Medical Genetics. Part A|June 11, 2026
Disparities in Diagnostic Yield of Genetic Testing in Children and Adolescents With Vascular Malformations and/or Overgrowth: A Single Site ExperienceJanette diMonda, Rana Al-Jaberi, Mustafa A Khader, et al.
The Journal of Pediatrics|January 13, 2005
Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effectJan M Wit, Lyset T M Rekers-Mombarg, Gordon B Cutler, et al.
Annals of the Rheumatic Diseases|April 16, 2015
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind studyJosef S Smolen, Michael E Weinblatt, Désirée van der Heijde, et al.
Pediatrics|February 20, 2021
Improving Parent-Child Interactions in Pediatric Health Care: A Two-Site Randomized Controlled TrialErin Roby, Elizabeth B Miller, Daniel S Shaw, et al.
Pageof 3